Cancer Cure PatentBook (CaCPB)™
Revolutionary Cancer Cure Patent Licensing
Patent pools were baby steps in bulk patent licensing but fell woefully short of inclusion and fair compensation for all patents. Patent pools exclude patents that are not “essential” to a technical standard, leaving patent pool licensees exposed to insanely expensive and time-consuming patent litigation from the owners of tens of thousands of non-pool patents.
PatentBooks™ revolutionizes how patent users (Subscribers) license all the patents needed for their oncology products, pharmaceuticals, or therapies. With the patent licensing database, users can effortlessly access a wide array of patents in the Cancer Cure PatentBook and streamline the licensing procedure with just a few clicks, eliminating the need for extensive negotiations.
And, Subscribers aren’t the only ones that benefit from PatentBooks...
Patent owners become Cancer Cure PatentBook Publishers for FREE, instantly earning income for each of their published patents, guaranteed! No expensive lawyers, painful litigation, or years of frustration trying to license individual patents. Each CaCPB Publisher receives accurate, transparent revenue, and knows who is and who is not Subscribed to the CaCPB.
Best of all, everyone knows some patents are better and more valuable than others. The CaCPB recognizes and rewards both top and high-quality patents. TAEUSworks™ sets uniform transparent rules and metrics that combine cross-checked opinions of medical experts, researchers, lawyers, and businesspeople to identify and compensate the best patents in the CaCPB. The TAEUSworks patent evaluation methodology has been used by 93 of the top 100 US patent holders for the past 25 years!
Publish your patent today to begin earning income from the Cancer Cure PatentBook!
CaCPB Publishers
Do you own patents used in cancer cures or oncology treatments?
As a patent owner, you have certainly discovered that getting paid by someone who uses your patent is difficult and expensive, if not impossible. Many users may not even realize you own the patent on that cancer cure product or therapy! You may have even chased after these patent users — spending endless years and a ton of money simply fighting for compensation.
When you publish your oncology and medical patents to the CaPB, you can rest assured that you will earn the revenue that you deserve from easy, legitimate licenses to your patented inventions.
The Cancer Cure PatentBook was created to help openly and transparently license patents specifically in the biomedical and oncology industry. CaPB Subscribers easily find and license all your and other Publisher patents. You earn income from all your patents. Your best patents earn superior income when evaluated with open, transparent TAEUSworks patent evaluations. With TAEUSworks and the CaPB, you will receive rapid, stress-free income based on the quality of your patent. Read and accept the CaPB Publisher Agreement today to get started!
CaCPB Subscribers
As a cancer cure product or services creator, we know that you don’t want to spend endless years negotiating licenses for patents your researchers and scientists must use to launch a competitive, life-saving product quickly. What you need is an easy way to license all the oncology patents for your product or service at a reasonable price, so that your product or service can get to market quickly, leaving potential litigation in the rear-view mirror.
At PatentBooks, we have your solution. In the Cancer Cure PatentBook, patent owners publish their medical patents, providing you the opportunity for an easy, one-click subscription to license all the patents your researchers need for an economical fee.
You no longer have to worry about negotiating hundreds or thousands of different license agreements to avoid patent litigation. Simply “plug-in” to the Cancer Cure PatentBook and accelerate your time-to-market, discovering the optimum route to profit while making a real difference. Become a Subscriber today to receive all the benefits that PatentBooks provides!
Patent Evaluation
Our team uses the TAEUSworks™ Evaluation Criteria to evaluate all patents published to the Cancer Cure PatentBook. Once evaluated, each patent will be placed in one of three tiers based on the quality and number of patents.
These separate tiers determine how much the Subscriber will pay for their patent licensing, as well as how much revenue will be distributed to the Publisher of the patent.
Benefits of Using the CaCPB
Our mission at PatentBooks is to breed innovation in the medical and oncology industry as we bring patent Publishers and Subscribers together with features and benefits specific to each side.
Publisher Benefits
- All published patents earn Subscriber income
- TAEUSworks identifies the best patents for optimum compensation
- 10% off TAEUSworks for a limited time
- Competitive Subscriber flexibility
Subscriber Benefits
- License all CaCPB published patents
- Amnesty from past damages available
- Fixed price per CaCPB patent volume
- Payment terms available
- "CaCPB Licensed" marking available
Get Started with PatentBooks Today!
Whether you are a patent owner or patent user in the oncology and medical industry, the Cancer Cure PatentBook is here to simplify your patent licensing by offering a one-stop-shop for patent users to become Subscribers, while paying patent owners quality-based royalties on each and every one of their published patents.